Royal Bank of Canada »

Myriad Genetics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2011-09-30 $620k 33k 18.61
2011-06-30 $750k 35k 21.43

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Myriad Genetics

BlackRock
Vanguard Group
State Street Corporation
Millennium Management
Glenview Captal Management
D. E. Shaw & Co
Morgan Stanley
Jacobs Levy Equity Management
Geode Capital Management
Goldman Sachs Group
Camber Capital Management
Dimensional Fund Advisors
Charles Schwab Investment Management
AQR Capital Management
Assenagon Asset Management

View all funds holding Myriad Genetics